Foundation Venture Capital

https://www.foundationventure.com/

Last activity: 05.01.2022

Active

Foundation Venture Capital Group uses impact investing to provide pre-seed and seed venture funding to health related start up companies at its affiliated organizations.

Mentions

Overview

Investment Type

Venture Capital

Investment Stage

Pre-Seed; Seed

Mentions in press and media 23

Date	Title	Description
Sign up to see	Sign up to see	Sign up to see
May 24, 2021	Venture capital group Kaszek raises $1 bln in two funds for Latin America	SAO PAULO, May 24 (Reuters) - Venture capital firm Kaszek raised $1 billion in two funds aimed at investing in Latin American companies, it said in a statement on Monday. The firm said its Kaszek Ventures V fund will invest $475 million in ...
May 20, 2021	Pine Labs raises $285m in venture funding to reach $3bn valuation	Indian merchant payments platform Pine Labs has landed $285 million in venture funding, valuing the firm at $3 billion. Pine Labs has raised $423.2m since 2009 Featuring in the round are Baron Capital Group, Duro Capital, Marshall Wace, Moo...
Oct 28, 2019	Sensely Announces $15M in Venture Funding	SAN FRANCISCO, CA, Sensely has secured a fresh round of funding led by Aflac Corporate Ventures. >> Click here for more funding data on Sensely >> To export Sensely funding data to PDF and Excel, click here Sensely, a dig...
Apr 18, 2018	Visikol Receives Investment To Advance 3Screen Drug Discovery	Visikol Inc., established with an investment from Foundation Venture Capital Group (FVCG), an affiliate of New Jersey Health Foundation (NJHF), has secured a new round of funding led by industry executives, announced James M. Golubieski, pr...
Apr 18, 2018	Visikol Receives Investment To Advance 3Screen Drug Discovery	Visikol Inc., established with an investment from Foundation Venture Capital Group (FVCG), an affiliate of New Jersey Health Foundation (NJHF), has secured a new round of funding led by industry executives, announced James M. Golubieski, pr...
Jul 14, 2017	Actinobac Biomed Receives Up To $4.4M Investment	Actinobac Biomed Inc., a New Brunswick, N.J.-based biopharmaceutical company developing therapeutics for multiple indications, including blood cancers, autoimmune/inflammatory diseases, and HIV, received an investment of up to $4.4m from Ka...
Jul 12, 2017	Actinobac Biomed to Raise up to $4.4M	Actinobac Biomed Inc., started with an investment from Foundation Venture Capital Group (FVCG), Inc., an affiliate of New Jersey Health Foundation (NJHF), has received an investment from Kairos Ventures of up to $4.4 million to continue its...
Feb 24, 2016	Visikol Raises $500K in Funding	Visikol, Inc., a New Brunswick, N.J.-based developer of a versatile biological clearing agent that penetrates tissue and renders it transparent without causing structural damage, raised $500k in funding. Foundation Venture Capital Group, LL...
Oct 27, 2014	Actinobac Biomed Receives $905K STTR Phase II Award	Actinobac Biomed Inc., a New Brunswick, N.J.-based pharma companies, received a $905k Small Business Technology Transfer Grant (STTR) Phase II Award from the National Institutes of Health/ National Cancer Institute. The company will use the...
Feb 11, 2014	Baird Venture Capital Group Raising $150M For Fourth Fund	Share Share on Facebook Share on Twitter LinkedIn Email Reprints The venture capital arm of Milwaukee-based Robert W. Baird & Co. intends to raise $150 million for a fourth fund, according to a filing with the U.S. Securities & Exch...
Apr 19, 2013	NovoPedics Raises $500K from Foundation Venture Capital Group	NovoPedics, a developer of an implantable meniscus replacement/regeneration medical device, raised up to $500k from Foundation Venture Capital Group. The company intends to use the funding to develop its device. NovoPedics’s Meniscofix™, it...
Feb 23, 2013	Actinobac Biomed Raises $100K in Seed Financing	Actinobac Biomed Inc., a North Brunswick, NJ-based developer of pharmaceutical technologies, raised $100k in seed financing. Foundation Venture Capital Group (FVCG), an affiliate of New Jersey Health Foundation, made a follow on investment....
Feb 1, 2013	NJ foundation pumps another $5M into early stage biotech investment arm	Foundation Venture Capital Group has focused its investments solely on commercially viable technology vetted by the technology transfer office at the University of Medicine and Dentistry of New Jersey. A merger with Rutgers University in Ju...
Jan 29, 2013	Nokia invests $250 million in venture funding	Finnish mobile phone maker Nokia said on Tuesday it would invest $250 million in a new venture fund for mobile technology startups. It would be the third fund for Nokia Growth Partners, Nokia's global venture firm which invests in mobile ha...
Jan 28, 2013	MentiNova Raises $500K in Funding	MentiNova Inc., a developer of an oral medication to help treat symptoms of Parkinson’s disease, has raised $500k in funding. The capital was provided by Foundation Venture Capital Group. Co-founded by Dr. M. Maral Mouradian, the William Do...
Sep 10, 2012	Health foundation sets up $500K grant program to cover medical research funding gaps	Dr. George F. Heinrich, CEO of New Jersey Health Foundation, said in the statement: “An unmet funding need existed for researchers who are beyond the Annual Grants Program stage but not yet at FVCG investment stage.” The new program is in a...
Jun 29, 2012	Diagnostic biomarker for breast cancer secures seed funding	In an interview with Foundation Venture president James Golubieski, he said he is seeing plenty of investment opportunities crossing his desk, with three undergoing due diligence. Among his companies, which receive no more than $500,000, is...
Jun 18, 2011	Affineti Biologics Receives $500K Investment from Foundation Venture Capital Group	Affineti Biologics, a New Jersey-based company developing plaque-reducing dental hygiene products, has received a $500k investment from Foundation Venture Capital Group. The company intends to use the funds to advance its research in the de...
Jun 26, 2007	Snowdon wins $500K grant for parasitic disease	Snowdon, a New Brunswick, N.J., drug developer, received a $500,000 grant from the New Jersey Commission on Science & Technology. The grant matches $500,000 the company raised in March from the Foundation Venture Capital Group. Snowdon ...
	NJ foundation pumps another $5M into early stage biotech investment arm	A New Jersey foundation that funds research coming out of the state’s medical school has agreed to replenish its investment arm with $5 million to pump into biotechnology startups at the pre-seed stage — one of the most difficult stages for...
	Diagnostic biomarker for breast cancer secures seed funding	A diagnostic biomarker being developed to detect breast cancer has received $500,000 in seed funding. The New Brunswick, New Jersey-based GeneAssess will use the investment to validate its target molecule not only as a way to identify breas...
	Health foundation sets up $500K grant program to cover medical research funding gaps	A health foundation has created a grant program to avoid funding gaps for research scientists that can happen between the seed stage and later stages. New Jersey Health Foundation has allocated $500,000 for faculty at the eight schools that...

Reviews 0

FAQ about Foundation Venture Capital

What has the press written about Foundation Venture Capital?

Parsers VC has collected 23 articles mentioning Foundation Venture Capital, among them “Venture capital group Kaszek raises $1 bln in two funds for Latin America” (May 24, 2021) and “Pine Labs raises $285m in venture funding to reach $3bn valuation” (May 20, 2021).

Is Foundation Venture Capital still active?

Yes, Foundation Venture Capital is active; its latest activity on Parsers VC dates from Jan 5, 2022.